Glycosylphosphatidylinositol Anchor Biology and Pathophysiology

Glycosylphosphatidylinositol (GPI) anchors are complex glycolipid structures that tether a diverse repertoire of proteins to the outer leaflet of the eukaryotic plasma membrane, thereby regulating processes from signal transduction to cell adhesion. Biosynthesis of GPI anchors is initiated in the endoplasmic reticulum through a multistep pathway involving lipid remodelling and glycan assembly, followed by transamidase-mediated attachment to target proteins. Once attached, GPI-anchored proteins (GPI-APs) associate with membrane microdomains (“lipid rafts”) to facilitate sorting, trafficking and controlled release by specific phospholipases. Perturbations in GPI biogenesis or remodelling give rise to inherited glycosylphosphatidylinositol deficiency disorders (IGDs), which manifest as neurodevelopmental delay, epilepsy, hypotonia and multisystem anomalies. Defects may arise at the level of core glycan assembly, transamidase complex function or post-attachment lipid modifications, each of which can impair membrane localisation, signal transmission and proteolytic release. Clinically, IGDs span a spectrum from hyperphosphatasia mental retardation syndromes to congenital motor neuropathies, emphasising the global significance of GPI-anchor integrity for developmental biology and human health. Ongoing research into the structural basis of enzyme specificity, the dynamics of lipid microdomains and the roles of GPI-specific phospholipases is shedding light on potential therapeutic strategies, including small-molecule correction of remodelling defects and targeted modulation of GPI-AP release.

Research from Nature Portfolio

Recent structural studies have resolved the three-dimensional architecture of the human GPI transamidase complex bound to both substrate and product analogues, illuminating how the enzyme recognises a diverse range of proprotein signals and catalyses specific cleavage–ligation reactions. By capturing autoinhibitory loops and identifying subsite interactions, these structures reveal a multilevel safeguard mechanism that prevents unintended activation and ensures precise attachment of GPI anchors. Energetically unfavourable conformational rearrangements, driven by coordinated binding at transmembrane and luminal domains, underpin the catalytic cycle. These mechanistic insights expand our understanding of GPI-AP biogenesis and open avenues for design of modulators that could correct transamidase dysfunction in inherited GPI-anchor disorders.

Glycosylphosphatidylinositol Anchor Biology and Pathophysiology publication trend

The graph below shows the total number of articles in glycosylphosphatidylinositol anchor biology and pathophysiology across all publications each year (not limited to Nature Index journals).

Technical terms

Glycosylphosphatidylinositol (GPI) anchor: A glycolipid structure that covalently attaches proteins to the cell surface.

GPI-anchored protein (GPI-AP): A protein modified post-translationally with a GPI anchor to localise on the outer plasma membrane.

Transamidase: A multimeric enzyme complex that replaces a proprotein’s signal peptide with a GPI anchor via transamidation.

Phospholipase: An enzyme that cleaves lipid components of GPI anchors, enabling release of GPI-APs.

Inherited GPI deficiency disorders (IGDs): Genetic syndromes caused by pathogenic variants in GPI biosynthesis or remodelling genes, leading to multisystem clinical manifestations.

References

1. Structures of liganded glycosylphosphatidylinositol transamidase illuminate GPI-AP biogenesis. Nature Communications (2023).
2. Unlocking the signaling potential of GPI-anchored proteins through lipolytic cleavage. Trends in Cell Biology (2025).
3. The clinical and genetic spectrum of inherited glycosylphosphatidylinositol deficiency disorders. Brain (2024).
4. PIGK defects induce apoptosis in Purkinje cells and acceleration of neuroectodermal differentiation. Cell Death & Disease (2024).
5. Biosynthesis and biology of mammalian GPI-anchored proteins. Open Biology (2020).